The Hon. Arthur J. Tarnow entered a final judgment in the securities class action lawsuit Dougherty v. Esperion Therapeutics, Case No. 2:16-cv-10089, approving Lead Plaintiffs’ $18.25 million recovery.

The Hon. Arthur J. Tarnow entered an Order preliminarily approving a $18,250,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Esperion common stock between August 18, 2015 and September 28, 2015.

The Hon. Arthur J. Tarnow issued an Order granting Plaintiffs’ motion for class certification in its entirety in Dougherty v. Esperion Therapeutics, Inc.

The Honorable R. Steven Whalen certified a class of shareholders in Dougherty v. Esperion Therapeutics, Inc. et al, No. 2:16-cv-10089, a securities fraud class action involving Defendants’ materially misleading statements and omissions concerning a cardiovascular outcomes trial for the Company’s lead drug candidate.

The Sixth Circuit Court of Appeals reversed and remanded the lower court’s dismissal of the securities class action filed on behalf of a putative class of Esperion Therapeutics, Inc. investors.